Literature DB >> 34351529

Reduction trend of mcr-1 circulation in Emilia-Romagna Region, Italy.

Carlo Gagliotti1, Luca Bolzoni2, Edoardo Carretto3, Mario Sarti4, Enrico Ricchizzi5, Simone Ambretti6, Agostino Barozzi7, Chiara Bracchi2, Massimo Confalonieri8, Ilaria Menozzi2, Marina Morganti2, Maria Federica Pedna9, Vittorio Sambri9,10, Erika Scaltriti2, Roberta Schiavo8, Laura Soliani2, Martina Tambassi2, Claudia Venturelli4, Carlo Biagetti11, Rossella Buttazzi5, Adriana Calderaro12, Chiara Casadio13, Marianna Meschiari14, Fabio Tumietto15, Giuseppe Diegoli13, Stefano Pongolini2, Maria Luisa Moro5.   

Abstract

This study aims to describe trends of mcr-positive Enterobacterales in humans based on laboratory surveillance with a defined catchment population. The data source is the Micro-RER surveillance system, established in Emilia-Romagna region (Italy), to monitor the trend of mcr resistance. Enterobacterales isolates from human clinical samples with minimum inhibitory concentration (MIC) ≥ 2 mg/L for colistin were sent to the study reference laboratory for the detection of mcr genes. Isolates prospectively collected in the period 2018-2020 were considered for the assessment of population rates and trends; further analyses were carried out for the evaluation of clonality and horizontal mcr gene transfer. Previous isolates from local laboratory collection were also described. In the period 2018-2020, 1164 isolates were sent to the reference laboratory, and 51 (4.4%) were confirmed as mcr-positive: 50 mcr-1 (42 Escherichia coli, 6 Klebsiella pneumoniae, 2 Salmonella enterica) and 1 mcr-4 (Enterobacter cloacae). The number of mcr-positive isolates dropped from 24 in the first half of 2018 to 3 in the whole of 2020 (trend p value < 0.001). Genomic analyses showed the predominant role of the horizontal transfer of mcr genes through plasmids or dissemination of transposable elements compared to clonal dissemination of mcr-positive microorganisms. The study results demonstrate a substantial decrease in the circulation of mcr-1 plasmid genes in Emilia-Romagna Region.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Antibiotic resistance; Antimicrobials for veterinary use; Clonal dissemination; Colistin; Enterobacterales; Horizontal transfer; Humans; Mcr; One Health approach

Mesh:

Substances:

Year:  2021        PMID: 34351529     DOI: 10.1007/s10096-021-04318-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  3 in total

1.  Multicenter study of automated systems for colistin susceptibility testing.

Authors:  Ahalieyah Anantharajah; Youri Glupczynski; Martin Hoebeke; Pierre Bogaerts; Philippe Declercq; Olivier Denis; Julie Descy; Katelijne Floré; Koen Magerman; Hector Rodriguez-Villalobos; Anne-Marie Van den Abeele; Te-Din Huang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-06       Impact factor: 3.267

2.  Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp.

Authors:  E Matuschek; J Åhman; C Webster; G Kahlmeter
Journal:  Clin Microbiol Infect       Date:  2017-12-05       Impact factor: 8.067

3.  Characterization of the global distribution and diversified plasmid reservoirs of the colistin resistance gene mcr-9.

Authors:  Ying Li; Xiaoyi Dai; Jing Zeng; Yan Gao; Zhikun Zhang; Luhua Zhang
Journal:  Sci Rep       Date:  2020-05-15       Impact factor: 4.379

  3 in total
  1 in total

1.  Longitudinal study of the mcr-1 gene prevalence in Spanish food-producing pigs from 1998 to 2021 and its relationship with the use of polymyxins.

Authors:  Pedro Miguela-Villoldo; Miguel A Moreno; David Rodríguez-Lázaro; Alejandro Gallardo; Marta Hernández; Tania Serrano; José L Sáez; Cristina de Frutos; Montserrat Agüero; Alberto Quesada; Lucas Domínguez; María Ugarte-Ruiz
Journal:  Porcine Health Manag       Date:  2022-03-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.